Mark E. Schneiderhan

Author

University of Minnesota, Duluth ORCID

Also Known As

M Schneiderhan, MARK E. SCHNEIDERHAN, Mark E Schneiderhan, Mark E. Schneiderhan, Mark Schneiderhan

Publications

253

Citations

H-Index

Concepts

All Affiliations

University of Minnesota, Duluth University of Illinois Chicago University of Minnesota University of Minnesota Medical Center Illinois College

About

Mark E. Schneiderhan is an author at University of Minnesota, Duluth specializing in medicine, psychiatry, and psychopharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	111
2	Social Sciences	3	3	49
3	Health Sciences	1	1	17
4	Nursing	1	1	12
5	Anesthesia	1	1	10

Mark E. Schneiderhan

Publications

199

Citations

H-Index

Page 1

	Year	Citations
Assessment of a Point‐of‐Care Metabolic Risk Screening Program in Outpatients Receiving Antipsychotic Agents Mark E. Schneiderhan, Catherine Batscha, Cherise Rosen Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2009	37
Attenuation of Antipsychotic-Induced Hyperprolactinemia with Clozapine Mark Bunker, Patricia A. Marken, Mark E. Schneiderhan, Journal of Child and Adolescent Psychopharmacology Antipsychotic-induced HyperprolactinemiaConventional Antipsychotic TherapyPsychiatryPsychotic DisorderPsychotropic Medication	1997	23
Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management Jacob T. Brown, Jeffrey R. Bishop, Mark E. Schneiderhan Mental Health Clinician Drug SelectionPsychotropic MedicationPharmacotherapyAdverse Drug ReactionPolymorphic Drug	2020	23
Is Acetazolamide Similar to Topiramate for Reversal of Antipsychotic-Induced Weight Gain? Mark E. Schneiderhan, Robert G. Marvin American Journal of Therapeutics Metabolic DisorderPsychotropic MedicationSignificant Weight LossPsychopharmacologyPharmacotherapy	2007	17
Twelve-Month Prospective Randomized Study of Pharmacists Utilizing Point-Of-Care Testing for Metabolic Syndrome and Related Conditions in Subjects Prescribed Antipsychotics Mark E. Schneiderhan, Sara M Shuster, Cynthia Davey The Primary Care Companion For CNS Disorders	2014	15
Treatment Settings and Metabolic Monitoring for People Experiencing First-Episode Psychosis Catherine Batscha, Mark E. Schneiderhan, Yachana Kataria, Journal of Psychosocial Nursing and Mental Health Services Metabolic SyndromeBlood PressurePsychiatryPsychotic DisorderMedicine	2010	14
Pharmacogenomics to support mental health medication therapy management: Clinical practice considerations and a conceptual framework to enhance patient care Jeffrey R. Bishop, Mark E. Schneiderhan, Tiana Butler, JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY	2023	13
Psychosocial Versus Biomedical Risk Factors in Kevorkian's First Forty-Seven Physician-Assisted Deaths Kalman J. Kaplan, Flint Lachenmeier, Martin Harrow, OMEGA - Journal of Death and Dying	2000	12
Autonomy, gender, and preference for paternalistic or informative physicians: a study of the doctor-patient relation. Kalman J. Kaplan, Mark E. Schneiderhan, Martin Harrow, PubMed NursingFamily MedicineMedical Decision MakingPrimary CareMedical Ethics	2002	12
The Neurobiology of Schizophrenia Robert A. Littrell, Mark E. Schneiderhan Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy NeuropsychologyPsychopharmacologySocial SciencesDopamine AntagonismCognitive Neuroscience	1996	12

Page 1